Search research articles
Contact Us
Filters
Showing results (171-180 of 189) with videos related to
Page
of 19
Sort By:
FEBS Open Bio
|
May 8, 2026
Cyclic azapeptide CD36 ligand attenuates cardiac injury and reduces long-chain fatty acid accumulation after myocardial ischemia-reperfusion in mice
Jade Gauvin, Naghme Radmannia, David N Huynh, et al.
Chemistry & Biology
|
March 2, 2010
Small-molecule ligands of GD2 ganglioside, designed from NMR studies, exhibit induced-fit binding and bioactivity
Wenyong Tong, Martin Gagnon, Tara Sprules, et al.
Atherosclerosis
|
July 30, 2020
Atheroprotective and atheroregressive potential of azapeptide derivatives of GHRP-6 as selective CD36 ligands in apolipoprotein E-deficient mice
Geneviève Frégeau, Roger Sarduy, Hanan Elimam, et al.
Journal of Medicinal Chemistry
|
September 22, 2025
<i>p</i>-Alkoxy-Substituted Anisomycins with Potent Anti-Trypanosomiasis Activity and Expanded Modes of Action
Kajumee Bora Bhowal, Anh Minh Thao Nguyen, Ana Victoria Ibarra-Meneses, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 23, 2026
Rytvela, an allosteric modulator of the interleukin-1 receptor, prevents preterm birth and neonatal complications in mice while nifedipine is ineffective
Tiffany Habelrih, Béatrice Ferri, Sarah-Eve Loiselle, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 28, 2022
Early diagnosis and treatment of Alzheimer's disease by targeting toxic soluble Aβ oligomers
Maram Habashi, Suresh Vutla, Kuldeep Tripathi, et al.
American Journal of Obstetrics and Gynecology
|
October 16, 2022
Pharmacodynamic characterization of rytvela, a novel allosteric anti-inflammatory therapeutic, to prevent preterm birth and improve fetal and neonatal outcomes
Tiffany Habelrih, David-Étienne Tremblay, Erica Di Battista, et al.
The Journal of Biological Chemistry
|
June 17, 2010
A novel biased allosteric compound inhibitor of parturition selectively impedes the prostaglandin F2alpha-mediated Rho/ROCK signaling pathway
Eugénie Goupil, Danaë Tassy, Carine Bourguet, et al.
Journal of Medicinal Chemistry
|
January 8, 2019
Functional Selectivity Revealed by N-Methylation Scanning of Human Urotensin II and Related Peptides
Francesco Merlino, Étienne Billard, Ali M Yousif, et al.
Scientific Reports
|
September 11, 2019
Immunometabolic modulation of retinal inflammation by CD36 ligand
Katia Mellal, Samy Omri, Mukandila Mulumba, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 189) with videos related to
Sort By:
Page
of 19
FEBS Open Bio
|
May 8, 2026
Cyclic azapeptide CD36 ligand attenuates cardiac injury and reduces long-chain fatty acid accumulation after myocardial ischemia-reperfusion in mice
Jade Gauvin, Naghme Radmannia, David N Huynh, et al.
Chemistry & Biology
|
March 2, 2010
Small-molecule ligands of GD2 ganglioside, designed from NMR studies, exhibit induced-fit binding and bioactivity
Wenyong Tong, Martin Gagnon, Tara Sprules, et al.
Atherosclerosis
|
July 30, 2020
Atheroprotective and atheroregressive potential of azapeptide derivatives of GHRP-6 as selective CD36 ligands in apolipoprotein E-deficient mice
Geneviève Frégeau, Roger Sarduy, Hanan Elimam, et al.
Journal of Medicinal Chemistry
|
September 22, 2025
<i>p</i>-Alkoxy-Substituted Anisomycins with Potent Anti-Trypanosomiasis Activity and Expanded Modes of Action
Kajumee Bora Bhowal, Anh Minh Thao Nguyen, Ana Victoria Ibarra-Meneses, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 23, 2026
Rytvela, an allosteric modulator of the interleukin-1 receptor, prevents preterm birth and neonatal complications in mice while nifedipine is ineffective
Tiffany Habelrih, Béatrice Ferri, Sarah-Eve Loiselle, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 28, 2022
Early diagnosis and treatment of Alzheimer's disease by targeting toxic soluble Aβ oligomers
Maram Habashi, Suresh Vutla, Kuldeep Tripathi, et al.
American Journal of Obstetrics and Gynecology
|
October 16, 2022
Pharmacodynamic characterization of rytvela, a novel allosteric anti-inflammatory therapeutic, to prevent preterm birth and improve fetal and neonatal outcomes
Tiffany Habelrih, David-Étienne Tremblay, Erica Di Battista, et al.
The Journal of Biological Chemistry
|
June 17, 2010
A novel biased allosteric compound inhibitor of parturition selectively impedes the prostaglandin F2alpha-mediated Rho/ROCK signaling pathway
Eugénie Goupil, Danaë Tassy, Carine Bourguet, et al.
Journal of Medicinal Chemistry
|
January 8, 2019
Functional Selectivity Revealed by N-Methylation Scanning of Human Urotensin II and Related Peptides
Francesco Merlino, Étienne Billard, Ali M Yousif, et al.
Scientific Reports
|
September 11, 2019
Immunometabolic modulation of retinal inflammation by CD36 ligand
Katia Mellal, Samy Omri, Mukandila Mulumba, et al.
Page
of 19